First-biopsy diagnostic rate in sinonasal malignant lymphoma: a single-center retrospective study of 24 cases

Sinonasal malignant lymphoma accounts for approximately 1% of head and neck malignancies, and necrosis often precludes diagnosis on a single biopsy. To determine the first-biopsy diagnostic rate by site of origin, histologic subtype, and biopsy method, and to describe the modifications made at repeat biopsy in non-diagnostic cases. We retrospectively reviewed 24 patients with sinonasal malignant lymphoma at a single university hospital (2014–2024; median age 68.5 years; 15 men, 9 women). Subtypes were diffuse large B-cell lymphoma (DLBCL; 12), extranodal NK/T-cell lymphoma (ENKL; 8), MALT lymphoma (2), and others (2); sites were the nasal cavity (12) and maxillary (6), ethmoid (5), and sphenoid (1) sinuses. The overall first-biopsy diagnostic rate was 70.8% (17/24): 75.0% for DLBCL (9/12) and ENKL (6/8), 83.3% (10/12) for the nasal cavity, and 58.3% (7/12) for the paranasal sinuses (p = 0.371). Five of seven non-diagnostic cases involved the paranasal sinuses, with only non-specific inflammation and necrosis. Approximately 30% of cases were not diagnosed at the first biopsy, mostly paranasal sinus lesions. Although site differences were not significant, clinicians should anticipate repeat biopsy for paranasal sinus lesions; general anesthesia may be considered when adequate sampling is difficult under local anesthesia.

Authors

Publication Details

Journal
Figshare
Published
2026-11-17
DOI
https://doi.org/10.6084/m9.figshare.35039112
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

First-biopsy diagnostic rate in sinonasal malignant lymphoma: a single-center retrospective study of 24 cases

Yumi Takemiya, Kishiko Sunami
1 links
Figshare
Lymphoma Diagnosis and Treatment
article

First-biopsy diagnostic rate in sinonasal malignant lymphoma: a single-center retrospective study of 24 cases

Yumi Takemiya, Kishiko Sunami
article en

Abstract

Sinonasal malignant lymphoma accounts for approximately 1% of head and neck malignancies, and necrosis often precludes diagnosis on a single biopsy. To determine the first-biopsy diagnostic rate by site of origin, histologic subtype, and biopsy method, and to describe the modifications made at repeat biopsy in non-diagnostic cases. We retrospectively reviewed 24 patients with sinonasal malignant lymphoma at a single university hospital (2014–2024; median age 68.5 years; 15 men, 9 women). Subtypes were diffuse large B-cell lymphoma (DLBCL; 12), extranodal NK/T-cell lymphoma (ENKL; 8), MALT lymphoma (2), and others (2); sites were the nasal cavity (12) and maxillary (6), ethmoid (5), and sphenoid (1) sinuses. The overall first-biopsy diagnostic rate was 70.8% (17/24): 75.0% for DLBCL (9/12) and ENKL (6/8), 83.3% (10/12) for the nasal cavity, and 58.3% (7/12) for the paranasal sinuses (p = 0.371). Five of seven non-diagnostic cases involved the paranasal sinuses, with only non-specific inflammation and necrosis. Approximately 30% of cases were not diagnosed at the first biopsy, mostly paranasal sinus lesions. Although site differences were not significant, clinicians should anticipate repeat biopsy for paranasal sinus lesions; general anesthesia may be considered when adequate sampling is difficult under local anesthesia.

Figshare
Good health and well-being
Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon